Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000174718 | SCV000226075 | uncertain significance | not provided | 2014-05-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000820524 | SCV000961240 | benign | Primary ciliary dyskinesia | 2024-01-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000820524 | SCV002718096 | uncertain significance | Primary ciliary dyskinesia | 2023-12-15 | criteria provided, single submitter | clinical testing | The c.1955G>A (p.S652N) alteration is located in exon 14 (coding exon 14) of the DNAH5 gene. This alteration results from a G to A substitution at nucleotide position 1955, causing the serine (S) at amino acid position 652 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Natera, |
RCV000820524 | SCV001462735 | uncertain significance | Primary ciliary dyskinesia | 2019-10-28 | no assertion criteria provided | clinical testing |